Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illumina’s technologies are industry standards in next-generation sequencing and microarray-based genetic analysis. Their products are used globally in research, clinical diagnostics, population-scale studies, oncology applications, reproductive health screening, infectious disease surveillance, and more. The company does not develop therapeutics but enables discovery through its genomic tools. Clinical results pertain to the performance of their instruments—such as high accuracy in variant calling with DRAGEN software—and their adoption in major global projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Illumina.